George Adel: Advancing Stroke Management at El Mabara Hospital Through Collaborative ICU Engagement
George Adel, Product Specialist at EVER Pharma (Africa), shared on LinkedIn:
”When you position yourself as a scientific resource rather than just a representative, you don’t just participate in the market you help shape it.
Today at El Mabara Hospital, it was all about partnering with the ICU team to elevate stroke management.
By aligning the clinical benefits of Cerebrolysin (right regimen) with the latest global guidelines, we aren’t just discussing a product, we are actively driving market growth and helping doctors optimize patient recovery.
A sincere thank you to Dr. Peter Wadie for always challenging me to grow and giving me the professional backing to execute these steps.
And to Dr. Sally Moheb, thank you for your encouragement and for always believing in my vision it really drives me to keep growing.”
Stay updated with Hemostasis Today.
-
May 18, 2026, 13:36Zain Khalpey: In Cardiovascular Medicine Flow Is Everything
-
May 18, 2026, 13:33Astha Thakkar: Three Things to Know Before Your IV Iron Infusion
-
May 18, 2026, 13:29Brian O Mahony: Ahead of the World Health Assembly in Geneva
-
May 18, 2026, 13:24Marian Galovic: When, Why and How to Perform an EEG After Stroke?
-
May 18, 2026, 13:23Behnood Bikdeli: A Wonderful Experience at the International Symposium on Thrombosis and Vessels
-
May 18, 2026, 13:16Wolfgang Miesbach: New Editorial Highlights – 6 Year Outcomes of Hemophilia B Gene Therapy
-
May 18, 2026, 13:10Ritika Jankar: Hemophilia Market Size to Reach USD 23.46 Billion by 2035
-
May 18, 2026, 13:10Natasha Kazi: Early Anticoagulation Linked to Better Outcomes in Acute PE
-
May 18, 2026, 13:02Paris Margaritis: Native Cellular Biology and the Future of Durable Hemophilia A Gene Therapy